![](/img/cover-not-exists.png)
Policy Practices to Maximise Social Benefit from Biosimilars
A, Inotai, M, Csanadi, D, Vitezic, I, Francetic, T, Tesar, T, Bochenek, L, Lorenzovici, P, Dylst, Z, KaloVolume:
9
Year:
2017
Language:
english
Journal:
Journal of Bioequivalence & Bioavailability
DOI:
10.4172/jbb.1000346
File:
PDF, 960 KB
english, 2017